Majd A.AbuAlrob: Is TPA Beneficial for Spinal Infarction?
Majd A.AbuAlrob, Editorial Board Member at BMC Neurology, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Stroke, adding:
“Is tPA beneficial for Spinal Infarction?
Arabic follows
Our study is now published in Stroke (American Heart Association).
Publishing in (Stroke) carries particular meaning for me.
It is the journal where the field’s definitions are written, including the 2013 AHA/ASA statement that formally placed spinal cord infarction inside the definition of stroke.
Placing a spinal cord paper there feels like returning the question to where it belongs.
The review process was the most demanding I have been through.
It reshaped the manuscript rather than polished it. Every causal-sounding word was interrogated.
Why this study is clinically unique:
Spinal cord infarction accounts for roughly 0.3% to 1.2% of all strokes. Its rarity has meant no trials, no guidelines, and no comparative data.
Thrombolysis has been given empirically, extrapolated from cerebral stroke protocols, supported by around twenty published case reports with almost certain publication bias.
This is the first direct comparison of the two strategies actually used at the bedside.
Using the TriNetX Global Collaborative Network, 68 covariates were balanced by 1:1 propensity score matching, leaving 96 patients per arm.
Periprocedural cases were excluded to isolate spontaneous infarction.
Standard care was associated with lower 180-day mortality (13.5% versus 29.2%; HR 0.423 [95% CI, 0.219 to 0.817]; P equals 0.008), with 180-day survival of 84.27% versus 68.69% and an E-value of 4.16.
Readmission and rehabilitation utilization did not differ.
The finding was unexpected.”
Title: Standard Antiplatelet Therapy Versus Thrombolysis in Acute Spontaneous Spinal Cord Infarction: A Propensity Score–Matched Analysis
Authors: Majd A AbuAlrob, Ali Al-Salahat, Khaled Zammar, Salman Al-Jerdi
Stay updated with Hemostasis Today.
-
Sep 24, 2026, 08:55Andres Gudino: Clot Characterization Through Hounsfield Units in Ischemic Stroke
-
Sep 24, 2026, 06:52Gina Sado: Screening-Detected Atrial Fibrillation Carries High Risk of Heart Failure
-
Sep 24, 2026, 06:33Benjamin Vipler: Optimal Oral Anticoagulation Choice in Atrial Fibrillation and Advanced CKD
-
Sep 24, 2026, 06:08Christopher Salerno: AI-Powered At-Home Anemia Screening Advances Telehealth Access
-
Sep 24, 2026, 05:38Aya Qattan: When a Normal CBC Does Not Mean Normal Iron Status
-
Sep 24, 2026, 05:11Mastering Warm Autoimmune Hemolytic Anemia Diagnosis and Practice – ASH Education
-
Sep 23, 2026, 16:04Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation